Literature DB >> 22075140

Multifocal papillary thyroid carcinoma associated with primary amyloid goiter.

Andrés Coca-Pelaz1, Blanca Vivanco-Allende, Cesar Alvarez-Marcos, Carlos Suarez-Nieto.   

Abstract

Amyloid goiter is a rare condition characterized by a diffuse enlargement of the thyroid gland due to amyloid deposition. Extremely uncommon is the development of differentiated carcinomas within this type of lesion. We describe to our knowledge the sixth case of a papillary thyroid carcinoma within an amyloid goiter, arising in a 45-year old woman with chronic renal failure due to primary amyloidosis. This is the first case of a multifocal papillary carcinoma within an amyloid goiter which produces compressive symptoms. The patient suffered a total thyroidectomy with the histological diagnosis of amyloid goiter with a multifocal papillary carcinoma of follicular variant. The Congo red stain confirmed the diagnosis of amyloid goiter. Two years and a half after the surgery the patient is free of recurrence. Amyloid goiter can hide a differentiated carcinoma. To diagnose and early treat this pathology, the knowledge of the possible association between an amyloid goiter and a differentiated carcinoma is needed.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22075140     DOI: 10.1016/j.anl.2011.09.003

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  Clinical characteristics and surgical resection of multifocal papillary thyroid carcinoma: 168 cases.

Authors:  Guomin Huang; Xiaofeng Tian; Yuhui Li; Fujian Ji
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature Review.

Authors:  Hélène Vergneault; Alexandre Terré; David Buob; Camille Buffet; Anael Dumont; Samuel Ardois; Léa Savey; Agathe Pardon; Pierre-Antoine Michel; Jean-Jacques Boffa; Gilles Grateau; Sophie Georgin-Lavialle
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.